↓ Skip to main content

Wiley Online Library

Umbilical cord mesenchymal stem cells for COVID-19 acute respiratory distress syndrome: A double-blind, phase 1/2a, randomized controlled trial

Overview of attention for article published in Stem Cells Translational Medicine, January 2021
Altmetric Badge

About this Attention Score

  • In the top 5% of all research outputs scored by Altmetric
  • One of the highest-scoring outputs from this source (#1 of 1,608)
  • High Attention Score compared to outputs of the same age (99th percentile)
  • High Attention Score compared to outputs of the same age and source (97th percentile)

Mentioned by

news
99 news outlets
blogs
6 blogs
policy
3 policy sources
twitter
81 X users
facebook
2 Facebook pages
reddit
2 Redditors

Citations

dimensions_citation
304 Dimensions

Readers on

mendeley
363 Mendeley
Title
Umbilical cord mesenchymal stem cells for COVID-19 acute respiratory distress syndrome: A double-blind, phase 1/2a, randomized controlled trial
Published in
Stem Cells Translational Medicine, January 2021
DOI 10.1002/sctm.20-0472
Pubmed ID
Authors

Giacomo Lanzoni, Elina Linetsky, Diego Correa, Shari Messinger Cayetano, Roger A. Alvarez, Dimitrios Kouroupis, Ana Alvarez Gil, Raffaella Poggioli, Phillip Ruiz, Antonio C. Marttos, Khemraj Hirani, Crystal A. Bell, Halina Kusack, Lisa Rafkin, David Baidal, Andrew Pastewski, Kunal Gawri, Clarissa Leñero, Alejandro M. A. Mantero, Sarah W. Metalonis, Xiaojing Wang, Luis Roque, Burlett Masters, Norma S. Kenyon, Enrique Ginzburg, Xiumin Xu, Jianming Tan, Arnold I. Caplan, Marilyn K. Glassberg, Rodolfo Alejandro, Camillo Ricordi

X Demographics

X Demographics

The data shown below were collected from the profiles of 81 X users who shared this research output. Click here to find out more about how the information was compiled.
Mendeley readers

Mendeley readers

The data shown below were compiled from readership statistics for 363 Mendeley readers of this research output. Click here to see the associated Mendeley record.

Geographical breakdown

Country Count As %
Unknown 363 100%

Demographic breakdown

Readers by professional status Count As %
Student > Bachelor 46 13%
Researcher 32 9%
Student > Ph. D. Student 27 7%
Student > Master 25 7%
Student > Doctoral Student 17 5%
Other 48 13%
Unknown 168 46%
Readers by discipline Count As %
Medicine and Dentistry 69 19%
Biochemistry, Genetics and Molecular Biology 28 8%
Nursing and Health Professions 19 5%
Agricultural and Biological Sciences 15 4%
Immunology and Microbiology 15 4%
Other 38 10%
Unknown 179 49%
Attention Score in Context

Attention Score in Context

This research output has an Altmetric Attention Score of 825. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 25 March 2024.
All research outputs
#22,682
of 25,837,817 outputs
Outputs from Stem Cells Translational Medicine
#1
of 1,608 outputs
Outputs of similar age
#885
of 530,381 outputs
Outputs of similar age from Stem Cells Translational Medicine
#1
of 41 outputs
Altmetric has tracked 25,837,817 research outputs across all sources so far. Compared to these this one has done particularly well and is in the 99th percentile: it's in the top 5% of all research outputs ever tracked by Altmetric.
So far Altmetric has tracked 1,608 research outputs from this source. They typically receive a lot more attention than average, with a mean Attention Score of 20.6. This one has done particularly well, scoring higher than 99% of its peers.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 530,381 tracked outputs that were published within six weeks on either side of this one in any source. This one has done particularly well, scoring higher than 99% of its contemporaries.
We're also able to compare this research output to 41 others from the same source and published within six weeks on either side of this one. This one has done particularly well, scoring higher than 97% of its contemporaries.